EP3385395
AÐFERÐIR VIÐ AÐ MEÐHÖNDLA KRABBAMEINSSJÚKLINGA MEÐ FARNESYL TRANSFERASA HEMLUM
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
16.8.2016EP published:
29.1.2020EP application number:
18173134.0
EP translation filed:
27.4.2020Grant published:
15.5.2020EPO information:
European Patent Register
Max expiry date:
15.8.2036Expiry date:
15.8.2024
Title:
METHODS OF TREATING CANCER PATIENTS WITH FARNESYL TRANSFERASE INHIBITORS
Timeline
Today
16.8.2016EP application
29.1.2020EP Publication
27.4.2020Translation submitted
15.5.2020Registration published
15.8.2024Expires
Owner
Name:
Kura Oncology, Inc.Address:
3033 Science Park Road, Suite 220, San Diego, CA 92121, US
Inventor
Name:
GUALBERTO, AntonioAddress:
Acton, MA 01720, US
Name:
SCHOLZ, Catherine RoseAddress:
North Reading,MA 01864, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201562206194 PDate:
17.8.2015Country:
US
Number:
201562218927 PDate:
15.9.2015Country:
US
Number:
201562241019 PDate:
13.10.2015Country:
US
Number:
201662310582 PDate:
18.3.2016Country:
US
Number:
201662372662 PDate:
9.8.2016Country:
US
Classification
Categories:
C12Q 1/68
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 8.7.2020
Expires: 15.8.2021
Payer: Árnason Faktor ehf.
Number: 6
Paid: 12.7.2021
Expires: 15.8.2022
Payer: Árnason Faktor ehf.
Number: 7
Paid: 5.7.2022
Expires: 15.8.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 11.7.2023
Expires: 15.8.2024
Payer: Árnason Faktor ehf.